Susquehanna International »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Susquehanna International

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.8M 4.0M 1.19
2024-03-31 $3.9M 4.0M 0.97
2023-09-30 $1.1M 1.2M 0.94

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Costco Wholesale Corporation (COST)
Advanced Micro Devices (AMD)
Netflix (NFLX)

View all positions for Susquehanna International

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1